Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

American heart journal·2017

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Alimentary pharmacology & therapeutics·2015

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Lancet (London, England)·2015

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy.

Heart (British Cardiac Society)·2014

Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.

Alimentary pharmacology & therapeutics·2010

Cardiac amyloidosis and coronary artery disease: an overlooked clinical intersection.

Coronary artery disease·2026

Joint association of high-sensitivity C-reactive protein-triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study.

Coronary artery disease·2026

In-hospital and mid-term outcomes of catheter-induced iatrogenic coronary artery dissection: a retrospective case-control study.

Coronary artery disease·2026

The C-reactive protein-albumin-lymphocyte index is associated with coronary collateral circulation in patients with chronic total occlusion.

Coronary artery disease·2026

Prior percutaneous coronary intervention versus deferral in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis of randomized controlled trials.

Coronary artery disease·2026

Long-term outcome between two different revascularization strategies for patients with left main coronary artery disease and concomitant chronic total occlusion of right coronary artery disease.

Coronary artery disease·2026

Chemical methods for O-GlcNAc detection and preparation of O-GlcNAc modified proteins.

Glycobiology·2026

β‑Cyclodextrin/Nerolidol Inclusion Complex as a Potential Ecofriendly Antifungal System against Botrytis cinerea in Postharvest Strawberries.

ACS omega·2026

PNA-ligand conjugates enable site-selective and directional targeting of adjacent G-quadruplexes.

Chemical science·2026

Diversity of Approaches to the Synthesis of Phosphoryl Guanidine Oligonucleotides.

ACS omega·2026

Synthesis of USP Grade [2,3,7-13C3]-Nicotinamide for Human Pharmacokinetic Studies.

Journal of labelled compounds & radiopharmaceuticals·2026

Ganoderic Acids Alleviate Dexamethasone-Induced Muscle Atrophy Potentially via Regulating Protein Synthesis/Degradation, Attenuating Oxidative Stress, and Antagonizing Glucocorticoid Receptor.

Phytotherapy research : PTR·2026

Related Experiment Videos

Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction

Related Concept Videos

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy.

Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.

Cardiac amyloidosis and coronary artery disease: an overlooked clinical intersection.

Joint association of high-sensitivity C-reactive protein-triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study.

In-hospital and mid-term outcomes of catheter-induced iatrogenic coronary artery dissection: a retrospective case-control study.

The C-reactive protein-albumin-lymphocyte index is associated with coronary collateral circulation in patients with chronic total occlusion.

Prior percutaneous coronary intervention versus deferral in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis of randomized controlled trials.

Long-term outcome between two different revascularization strategies for patients with left main coronary artery disease and concomitant chronic total occlusion of right coronary artery disease.

Chemical methods for O-GlcNAc detection and preparation of O-GlcNAc modified proteins.

β‑Cyclodextrin/Nerolidol Inclusion Complex as a Potential Ecofriendly Antifungal System against Botrytis cinerea in Postharvest Strawberries.

PNA-ligand conjugates enable site-selective and directional targeting of adjacent G-quadruplexes.

Diversity of Approaches to the Synthesis of Phosphoryl Guanidine Oligonucleotides.

Synthesis of USP Grade [2,3,7-13C3]-Nicotinamide for Human Pharmacokinetic Studies.

Ganoderic Acids Alleviate Dexamethasone-Induced Muscle Atrophy Potentially via Regulating Protein Synthesis/Degradation, Attenuating Oxidative Stress, and Antagonizing Glucocorticoid Receptor.

Related Experiment Videos

Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction

Related Concept Videos

Related Articles